HUG - Geneva University Hospitals

OncoDaily

News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary

Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me

March, 2025

HUG – Geneva University Hospitals

Jul 24, 2024, 01:01 | Blog

Timothée Olivier: Interim data of early phase results from novel RAS inhibitor in pancreatic cancer

Timothée Olivier, Medical Oncologist at HUG – Geneva University Hospitals, shared his previous post on X,…

May 28, 2024, 14:05 | Blog

Timothée Olivier: How applying FDA censoring rules can double the PFS benefit by Vinay Prasad

Timothée Olivier, Medical Oncologist at HUG – Geneva University Hospitals, shared a post on X:…

May 27, 2024, 06:35 | Blog

Timothée Olivier: An academic study addressing a practical clinical question!

Timothée Olivier, Medical Oncologist at HUG – Geneva University Hospitals, shared a post on X:…

Apr 5, 2024, 18:16 | Insight

Timothée Olivier: NATALEE trial, adjuvant ribociclib 21 days/28 for… 3 years! Cost alert!!

Timothée Olivier, Medical Oncologist at HUG - Geneva University Hospitals, shared a post by the…

All: 4 Posts: 1 - 100

'

Meet the New AACR Board of Directores for 2025-2028 Term

'

Do Artificial Sweeteners Cause Cancer? Myths and Facts

'

King Charles III Hospitalized Following Side Effects from Cancer Treatment

'

Keith T. Flaherty has been elected as the AACR President-Elect for 2025-2026

'

MARIPOSA trial results presented at ELCC25 - BREAKING from Paris

Special Coverage

Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
ESMO 2024 Congress
September 13-17, 2024
ASCO Annual Meeting
May 30 - June 4, 2024
Yvonne Award 2024
May 31, 2024
OncoThon 2024, Online
Feb. 15, 2024
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023